45600 Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices 

pharmacy benefit managers, to integrate 

or avoid duplicating their educational 

programs or requirements? What other 

steps might FDA consider to make 

implementation less burdensome and 

more effective? 

IV. Additional Matters for 

Consideration 

1. What other steps should FDA take 

to operationalize the above described 

goals? 

2. Are there additional policy steps 

FDA should consider relating to the 

OPSC that are not identified in this 

notice? 

We invite interested parties to review 

these questions and submit comments to 

the docket for the OPSC to consider. In 

addition, we invite interested parties to 

submit additional policy considerations 

or recommendations for actions that 

FDA could or should undertake to help 

the Agency better address the opioid 

addiction crisis. 

V. References 

1. Gottlieb, Scott and J. Woodcock. 

‘‘Marshaling FDA Benefit-Risk Expertise to 

Address the Current Opioid Abuse 

Epidemic.’’ Journal of the American Medical 

Association. 2017;318(5):421–422. 

Doi:10.1001/jama.2017.9205. Available at 

http://jamanetwork.com/journals/jama/ 

fullarticle/2643333. Accessed August 2017. 

2. National Academies of Sciences, 

Engineering, and Medicine. ‘‘Pain 

Management and the Opioid Epidemic: 

Balancing Societal and Individual Benefits 

and Risks of Prescription Opioid Use (2017), 

Consensus Study Report.’’ Richard J. Bonnie, 

Morgan A. Ford, and Jonathan K. Phillips 

(eds.). Available at https://www.nap.edu/ 

catalog/24781/pain-management-and-theopioid-epidemic-balancing-societal-andindividual. Accessed August 2017. 

3. Dowell, D., T. M. Haegerich, and R. 

Chou. ‘‘CDC Guideline for Prescribing 

Opioids for Chronic Pain—United States, 

2016.’’ Item 6 in ‘‘Determining When to 

Initiate or Continue Opioids for Chronic 

Pain.’’ Morbidity and Mortality Weekly 

Report Recommendations and Reports 

2016;65(No. RR–1):1–49. DOI: http://

dx.doi.org/10.15585/mmwr.rr6501e1. 

Accessed August 2017. 

4. Bicket, M. C., J. J. Long, P. J. Pronovost, 

et al. ‘‘Prescription Opioid Analgesics 

Commonly Unused After Surgery, A 

Systematic Review.’’ JAMA Surgery. 

Published online August 2, 2017. 

DOI:10.1001/jamasurg.2017.0831. Available 

at http://jamanetwork.com/journals/ 

jamasurgery/fullarticle/2644905. Accessed 

August 2017. 

5. New York State Department of Health, 

Mandatory Prescriber Education. Available at 

https://www.health.ny.gov/professionals/ 

narcotic/mandatory_prescriber_education/. 

Accessed August 2017. 

Dated: September 26, 2017. 

Anna K. Abram, 

Deputy Commissioner for Policy, Planning, 

Legislation, and Analysis. 

[FR Doc. 2017–20905 Filed 9–28–17; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

[HHS–OS–0990–0281–60D] 

Agency Generic Information Collection 

Activities; Proposed Collection; Public 

Comment Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before November 28, 

2017. 

ADDRESSES: Submit your comments to 

Sherrette.Funn@hhs.gov or by calling 

(202) 795–7714. 

FOR FURTHER INFORMATION CONTACT: 

When submitting comments or 

requesting information, please include 

the document identifier 0990–0281–60D 

and project title for reference, to the 

Report Clearance Officer, Sherrette 

Funn. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Information Collection Request Title: 

Prevention Communication Formative 

Research—Revision—OMB No. 0990– 

0281. 

Abstract: The Office of Disease 

Prevention and Health Promotion 

(ODPHP) is focused on developing and 

disseminating health information to the 

public. ODPHP faces an increasingly 

urgent interest in finding effective ways 

to communicate health information to 

America’s diverse population. ODPHP 

strives to be responsive to the needs of 

America’s diverse audiences while 

simultaneously serving all Americans 

across a range of channels, from print to 

new communication technologies. To 

carry out prevention information efforts, 

ODPHP is committed to conducting 

formative and usability research to 

provide guidance on the development 

and implementation of their 

communication and education efforts. 

The information collected will be used 

to improve communication, products, 

and services that support key office 

activities including: Healthy People, 

Dietary Guidelines for Americans, 

Physical Activity Guidelines for 

Americans, healthfinder.gov, and 

increasing health care quality and 

patient safety. ODPHP communicates 

through its Web sites 

(www.healthfinder.gov, 

www.HealthyPeople.gov, 

www.health.gov) and through other 

channels including social media, print 

materials, interactive training modules, 

and reports. Data collection will be 

qualitative and quantitative and may 

include in-depth interviews, focus 

groups, web-based surveys, omnibus 

surveys, card sorting, and various forms 

of usability testing of materials and 

interactive tools to assess the public’s 

understanding of disease prevention 

and health promotion content, 

responses to prototype materials, and 

barriers to effective use. 

The program is requesting a 3-year 

clearance. 

Likely Respondents: Respondents are 

likely to be either consumers or health 

professionals. 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS

Data collection task Instrument/form name Number of 

respondents 

Number 

responses/ 

respondent 

Average burden/ 

response 

(in hours) 

Total response 

burden 

(in hours) 

In-depth interviews ............... Screener ............................... 1,500 1 10/60 250 

Interview ............................... 500 1 1.00 500 

Focus groups ........................ Screener ............................... 2,925 1 10/60 487.5 


asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 188 / Friday, September 29, 2017 / Notices 45601 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Data collection task Instrument/form name Number of 

respondents 

Number 

responses/ 

respondent 

Average burden/ 

response 

(in hours) 

Total response 

burden 

(in hours) 

Focus Group ......................... 975 1 1.50 1,462.5 

Intercept interviews ............... Interview ............................... 5,250 1 5/60 437.50 

Cognitive testing of instruments.Screener ............................... 150 1 10/60 25 

Cognitive Test ....................... 50 1 2.00 100 

Web-based surveys .............. Screener ............................... 30,000 1 5/60 2,500 

Survey ................................... 10,000 1 15/60 2,500 

Omnibus surveys .................. Survey ................................... 2,100 1 10/60 350 

Gatekeeper reviews .............. Review .................................. 325 1 30/60 162.5 

Card sorting .......................... Screener ............................... 600 1 10/60 100 

Card Sort .............................. 200 1 1.00 200 

Usability and prototype testing of materials (print and 

web).

Screener ...............................

Usability Test ........................

1,800 

600 

1 

1 

10/60 

1.00 

300 

600 

Total ............................... ............................................... .............................. .............................. .............................. 9,975.00 

Darius Taylor, 

Paperwork Reduction Act Reports Clearance 

Officer, Department of Health and Human 

Services. 

[FR Doc. 2017–20901 Filed 9–28–17; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; Review of Support of Competitive 

Research (SCORE) Award Applications. 

Date: October 18, 2017. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, Room 3AN 18, 45 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Rebecca H. Johnson, 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 

Natcher Building, Room 3AN18C, Bethesda, 

MD 20892, 301–594–2771, johnsonrh@

nigms.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives; 93.859, 

Biomedical Research and Research Training, 

National Institutes of Health, HHS) 

Dated: September 25, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20858 Filed 9–28–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Biomedical Imaging and Bioengineering 

Special Emphasis Panel; P41 BTRC 

Application Review (2018/01). 

Date: November 15–17, 2017. 

Time: 6:00 p.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Boston Hotel Buckminster, 645 

Beacon Street, Boston, MA 02215. 

Contact Person: John P. Holden, Ph.D., 

Scientific Review Officer, National Institutes 

of Health, National Institute of Biomedical 

Imaging, and Bioengineering, Bethesda, MD 

20892, (301) 496–8947, john.holden@nih.gov. 

Dated: September 25, 2017. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–20856 Filed 9–28–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Minority Health 

and Health Disparities; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 


asabaliauskas on DSKBBXCHB2PROD with NOTICES